{"database": "openregs", "table": "dockets", "rows": [["DEA-2022-0145", "DEA", "Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)", "Rulemaking", "2025-08-27T12:33:24Z", "0b0000648554cfe6"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["DEA-2022-0145"], "units": {}, "query_ms": 0.29827794060111046, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}